SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-036617
Filing Date
2017-05-31
Accepted
2017-05-31 17:17:04
Documents
3
Period of Report
2017-05-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-14536_18k.htm 8-K 23424
2 EX-99.1 a17-14536_1ex99d1.htm EX-99.1 7163
3 GRAPHIC g145361mmi001.jpg GRAPHIC 2380
  Complete submission text file 0001104659-17-036617.txt   35236
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32966 | Film No.: 17882279
SIC: 2836 Biological Products, (No Diagnostic Substances)